Paid Clinical Trials Santa Fe

Discover 162 paid clinical trials in Santa Fe, New Mexico. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 162

OBT076Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors

Recruiting

PHASE1

Sponsor:

Oxford BioTherapeutics Ltd

Location:

Santa Fe NM, Phoenix AZ, Los Angeles CA, Santa Monica CAshow 6 more

Code:

NCT04064359

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OBT076, a CD205-directed antibody-drug conjugate

Islatravir & LenacapavirStudy to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1

Recruiting

PHASE3

Sponsor:

Gilead Sciences

Location:

Santa Fe NM, El Paso TX, Denver CO, Phoenix AZshow 40 more

Code:

NCT06630299

Conditions

HIV-1-Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ISL/LEN

Antiretroviral Combinations

YL201A Study of YL201 in Patients with Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

MediLink Therapeutics (Suzhou) Co., Ltd.

Location:

Santa Fe NM, Dallas TX, San Antonio TX, Tyler TXshow 15 more

Code:

NCT05434234

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

YL201

DPX-Survivac & PembrolizumabDPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Recruiting

PHASE2

Sponsor:

ImmunoVaccine Technologies, Inc. (IMV Inc.)

Location:

Santa Fe NM, Omaha NE, Fountain Valley CA, Watertown SDshow 13 more

Code:

NCT04920617

Conditions

Relapsed Diffuse Large B-cell Lymphoma

Refractory Diffuse Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DPX-Survivac

Pembrolizumab

CPA

NBTXR3 with Anti-PD-1NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy

Recruiting

PHASE1

Sponsor:

Nanobiotix

Location:

Santa Fe NM, Sioux Falls SD, San Francisco CA, Chicago ILshow 8 more

Code:

NCT03589339

Conditions

Radiotherapy

Immunotherapy

Microsatellite Instability-High Solid Malignant Tumour

Metastasis from Malignant Tumor of Liver

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NBTXR3

SABR

Nivolumab

Pembrolizumab

JNJ-90301900 & CetuximabJNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Recruiting

PHASE3

Sponsor:

Johnson & Johnson Enterprise Innovation Inc.

Location:

Santa Fe NM, Oklahoma City OK, Laguna Hills CA, Newport Beach CAshow 6 more

Code:

NCT04892173

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma

Aged

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

JNJ-90301900 (NBTXR3)

Cetuximab

Radiation Therapy

LumiraDx TestEvaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Recruiting

Sponsor:

LumiraDx UK Limited

Location:

Santa Fe NM, Centennial CO, Thornton CO, Northglenn COshow 16 more

Code:

NCT04288921

Conditions

Influenza, Human

Respiratory Syncytial Virus Infections

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Swab

Hand ExercisesThe Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors

Recruiting

Sponsor:

Texas Woman's University

Location:

Santa Fe NM, Rio Rancho NM, Albuquerque NM

Code:

NCT05983380

Conditions

Breast Cancer Lymphedema

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Hand Mobility and Grip Strengthening Exercises

Usual Care

FrexalimabEfficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

Recruiting

PHASE2

Sponsor:

Sanofi

Location:

Santa Fe NM, Lubbock TX, Mesa AZ, Tucson AZshow 17 more

Code:

NCT05039840

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

SAR441344 IV

SAR441344 SC

Placebo IV

Placebo SC

Tec-DR, Tal-DRA Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Santa Fe NM, Omaha NE, Irvine CA, Duarte CAshow 8 more

Code:

NCT05552222

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Teclistamab

Daratumumab

Lenalidomide

Dexamethasone

Talquetamab